ENVERIC BIOSCIENCES, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
ENVERIC BIOSCIENCES, INC. (ENVB) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $8.30 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $8.30M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $4.91M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $4.68M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $3.76M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $8.30M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.91M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.68M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.76M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.85M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $4.29M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $2.24M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $3.11M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $3.50M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $6.36M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $2.29M 10-K · filed 2026-03-27 |
| 2023-09-30 | $4.27M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $7.08M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $12.56M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $17.72M 10-K · filed 2025-03-28 |
| 2022-09-30 | $21.20M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $18.01M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $21.69M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $17.36M 10-K · filed 2024-03-26 |
| 2021-09-30 | $21.45M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $20.62M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $22.66M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $1.58M 10-K/A · filed 2023-06-09 |
| 2020-09-30 | $340.90K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $441.39K 10-Q · filed 2021-08-13 |
| 2020-03-31 | $275.31K 10-Q · filed 2021-05-17 |
| 2019-12-31 | $43.71K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |